Per Malmström

121 – 130 of 159

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/963d7dbb-2152-4d38-8f2e-5bbc7e2344d2?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2000
Mark Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
Bergh, J ; Wiklund, T ; Erikstein, B ; Lidbrink, E ; Lindman, H ; Malmström, Per ^LU ; Kellokumpu-Lehtinen, P ; Bengtsson, N O ; Söderlund, G and Anker, G , et al. (2000) In The Lancet 356(9239). p.1384-1391
- Contribution to journal › Article
Mark Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
Sjöström, J ; Blomqvist, C ; Heikkilä, P ; Boguslawski, K V ; Räisänen-Sokolowski, A ; Bengtsson, N O ; Mjaaland, I ; Malmström, Per ^LU ; Ostenstadt, B and Bergh, J , et al. (2000) In Clinical Cancer Research 6(8). p.3103-3110
- Contribution to journal › Article
Mark Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
Hakamies-Blomqvist, L ; Luoma, M ; Sjöström, J ; Pluzanska, A ; Sjödin, M ; Mouridsen, H ; Ostenstad, B ; Mjaaland, I ; Ottosson-Lönn, S and Bergh, J , et al. (2000) In European Journal of Cancer 36(11). p.7-1411
- Contribution to journal › Article
Mark ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
Stål, O ; Borg, A ; Fernö, M ^LU ; Källström, A C ; Malmström, P ^LU and Nordenskjöld, B (2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550
- Contribution to journal › Article
1999
Mark Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
Linderholm, B. ; Gruvberger, S ^LU ; Fernö, M ^LU ; Bendahl, P-O ^LU and Malmström, Per ^LU (1999) In Breast Cancer Research and Treatment 57(1). p.98-98
- Contribution to journal › Published meeting abstract
Mark Predictive value of P53, MDM-2, P21-expression, KI-67 for response to docetaxel or methotrexate-fluorouracil (MF) in advanced breast cancer
Blomqvist, C. ; Sjöström, J ; von Boguslawski, K ; Heikkila, P ; Bengtsson, N-O ; Mjaaland, I ; Ostenstad, B ; Malmström, P ^LU ; Bergh, J. and Valvere, V , et al. (1999) In Breast Cancer Research and Treatment 57(1). p.61-61
- Contribution to journal › Published meeting abstract
Mark Predictive value c-erB-B2 expression for response to docetaxel (D) or methotrexate-fluorouracil (MF) in advanced breast cancer
Collan, J ; Sjöström, J ; von Boguslawski, K ; Franssila, K ; Bengtsson, N-O ; Mjaaland, I ; Østenstad, B ; Malmström, P ^LU ; Bergh, J. and Valvere, V , et al. (1999) In Breast Cancer Research and Treatment 57(1). p.64-64
- Contribution to journal › Published meeting abstract
1998
Mark Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
Fernö, M ^LU ; Bendahl, P-O ^LU and Malmström, P ^LU (1998) In Breast Cancer Research and Treatment 50(3).
- Contribution to journal › Published meeting abstract
Mark A dose intensity study of epirubicin weekly for disseminated breast cancer
Malmström, P. ^LU ; Malmberg, P ; Jönsson, P. E. ; Ingvar, C ; Loven, L and Rudenstam, CM (1998) In Breast Cancer Research and Treatment 50(3).
- Contribution to journal › Published meeting abstract
Mark Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
Jungnelius, U ; Ringborg, U ; Aamdal, S ; Mattsson, J ; Stierner, U ; Ingvar, C ^LU ; Malmström, P ^LU ; Andersson, R ; Karlsson, M and Willman, K , et al. (1998) In European Journal of Cancer 34(9). p.1368-1374
- Contribution to journal › Article